The journal Circulation has published a study on the safety of fully biodegradable coronary artery Igaki-Tamai stents implanted in humans,... Read More

Medtronic, Inc. announced today the start of the IN.PACT SFA II study, the company’s first US clinical trial for its... Read More

Today, Abbott announced the start of European clinicals trial to evaluate its new Esprit™ drug eluting bioresorbable vascular scaffold (BVS)... Read More

  Medtronic Inc has developed a new device  for the treatment of peripheral artery disease. This new FDA approved device,... Read More